1.
Off-label drug use in paediatric haemato-oncology patients: financial implications and proposed solutions for Belgian patients.
2.
3.
4.
5.
6.
7.
8.
Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort